135 related articles for article (PubMed ID: 17624688)
1. Psychosocial functioning and cocaine use during treatment: strength of relationship depends on type of urine-testing method.
Ghitza UE; Epstein DH; Preston KL
Drug Alcohol Depend; 2007 Dec; 91(2-3):169-77. PubMed ID: 17624688
[TBL] [Abstract][Full Text] [Related]
2. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR
Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.
Dürsteler-MacFarland KM; Farronato NS; Strasser J; Boss J; Kuntze MF; Petitjean SA; Bürki C; Wiesbeck GA
J Clin Psychopharmacol; 2013 Feb; 33(1):104-8. PubMed ID: 23277248
[TBL] [Abstract][Full Text] [Related]
4. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.
Grabowski J; Rhoades H; Stotts A; Cowan K; Kopecky C; Dougherty A; Moeller FG; Hassan S; Schmitz J
Neuropsychopharmacology; 2004 May; 29(5):969-81. PubMed ID: 15039761
[TBL] [Abstract][Full Text] [Related]
5. The brief abstinence test: voucher-based reinforcement of cocaine abstinence.
Robles E; Silverman K; Preston KL; Cone EJ; Katz E; Bigelow GE; Stitzer ML
Drug Alcohol Depend; 2000 Feb; 58(1-2):205-12. PubMed ID: 10669073
[TBL] [Abstract][Full Text] [Related]
6. Quantitative versus qualitative urinalysis for benzoylecgonine in clinical trials for the assessment of cocaine use.
Li SH; Chiang CN; Tai BC; Marschke CK; Hawks RL
Psychopharmacol Bull; 1995; 31(4):671-9. PubMed ID: 8851639
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of two intensities of psychosocial treatment for cocaine dependence.
Coviello DM; Alterman AI; Rutherford MJ; Cacciola JS; McKay JR; Zanis DA
Drug Alcohol Depend; 2001 Jan; 61(2):145-54. PubMed ID: 11137279
[TBL] [Abstract][Full Text] [Related]
8. DHEAS and POMS measures identify cocaine dependence treatment outcome.
Wilkins JN; Majewska MD; Van Gorp W; Li SH; Hinken C; Plotkin D; Setoda D
Psychoneuroendocrinology; 2005 Jan; 30(1):18-28. PubMed ID: 15358439
[TBL] [Abstract][Full Text] [Related]
9. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance.
Preston KL; Umbricht A; Epstein DH
Arch Gen Psychiatry; 2000 Apr; 57(4):395-404. PubMed ID: 10768702
[TBL] [Abstract][Full Text] [Related]
10. Cognitive impairment in methadone maintenance patients.
Mintzer MZ; Stitzer ML
Drug Alcohol Depend; 2002 Jun; 67(1):41-51. PubMed ID: 12062778
[TBL] [Abstract][Full Text] [Related]
11. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
[TBL] [Abstract][Full Text] [Related]
12. Methadone maintenance treatment: a protective factor for cocaine injection in a street-recruited cohort of heroin users.
Bravo MJ; Llorens N; Barrio G; Brugal MT; Santos S; Sordo L; de la Fuente L;
Drug Alcohol Depend; 2010 Nov; 112(1-2):62-8. PubMed ID: 20591582
[TBL] [Abstract][Full Text] [Related]
13. Cocaine use immediately prior to entry in an inpatient heroin detoxification unit as a predictor of discharges against medical advice.
Pérez de los Cobos J; Trujols J; Ribalta E; Casas M
Am J Drug Alcohol Abuse; 1997 May; 23(2):267-79. PubMed ID: 9143638
[TBL] [Abstract][Full Text] [Related]
14. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy.
Silverman K; Higgins ST; Brooner RK; Montoya ID; Cone EJ; Schuster CR; Preston KL
Arch Gen Psychiatry; 1996 May; 53(5):409-15. PubMed ID: 8624184
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of employment-based reinforcement of cocaine abstinence in injection drug users.
Silverman K; Wong CJ; Needham M; Diemer KN; Knealing T; Crone-Todd D; Fingerhood M; Nuzzo P; Kolodner K
J Appl Behav Anal; 2007; 40(3):387-410. PubMed ID: 17970256
[TBL] [Abstract][Full Text] [Related]
16. Antidepressants for cocaine dependence and problematic cocaine use.
Pani PP; Trogu E; Vecchi S; Amato L
Cochrane Database Syst Rev; 2011 Dec; (12):CD002950. PubMed ID: 22161371
[TBL] [Abstract][Full Text] [Related]
17. Personality traits of cocaine-dependent patients associated with cocaine-positive baseline urine at hospitalization.
de Los Cobos JP; Siñol N; Bañulus E; Batlle F; Tejero A; Trujols J
Am J Drug Alcohol Abuse; 2010 Jan; 36(1):52-6. PubMed ID: 20141397
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic.
O'Connor PG; Oliveto AH; Shi JM; Triffleman EG; Carroll KM; Kosten TR; Rounsaville BJ; Pakes JA; Schottenfeld RS
Am J Med; 1998 Aug; 105(2):100-5. PubMed ID: 9727815
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations.
Batki SL; Manfredi LB; Jacob P; Jones RT
J Clin Psychopharmacol; 1993 Aug; 13(4):243-50. PubMed ID: 8376611
[TBL] [Abstract][Full Text] [Related]
20. The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day.
Somoza E; Somoza P; Lewis D; Li SH; Winhusen T; Chiang N; Vocci F; Horn P; Elkashef A
Drug Alcohol Depend; 2008 Jan; 93(1-2):132-40. PubMed ID: 18029115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
